drugset
drugset / Trial / NCT00006478

Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma

NCT00006478 ↗

Phase 2 Terminated 19 enrolled University of Nebraska
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill cancer cells. Vaccine therapy may be an effective treatment for non-Hodgkin's lymphoma. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy following chemotherapy and peripheral stem cell transplantation in treating patients who have non-Hodgkin's lymphoma.

Timeline

Start
2000-10-11
Primary completion
2008-04-03
Completion
2008-04-03

Outcome

Outcome not reported

Stopped: “Genitope suspend drug development by decision made by the FDA March 6, 2008.”

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous lymphoma-derived idiotype vaccine Vaccine — Subcutaneous
Background keyhole limpet hemocyanin Vaccine — Subcutaneous
Background sargramostim Protein / enzyme biologic — Subcutaneous

Indications

lymphoma